Skip to main content

01.12.2012 | Short communication | Ausgabe 1/2012 Open Access

Molecular Cancer 1/2012

Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1

Molecular Cancer > Ausgabe 1/2012
Louise van der Weyden, Mark J Arends, Alistair G Rust, George Poulogiannis, Rebecca E McIntyre, David J Adams
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1476-4598-11-29) contains supplementary material, which is available to authorized users.
Mark J Arends, Alistair G Rust contributed equally to this work.

Competing interests

The authors declare they have no competing interests.

Author’s contributions

LvdW and DJA designed the experiments and performed the animal work; MJA performed the histopathological and immunohistopathological analysis; AGR and GP performed the bioinformatic statistical analysis; REM performed the micronucleus assay; LvdW wrote the manuscript with comments from all authors; all authors read and approved the final version of the manuscript.



CADM1 encodes an immunoglobulin superfamily (IGSF) cell adhesion molecule. Inactivation of CADM1, either by promoter hypermethylation or loss of heterozygosity, has been reported in a wide variety of tumor types, thus it has been postulated as a tumor suppressor gene.


We show for the first time that Cadm1 homozygous null mice die significantly faster than wildtype controls due to the spontaneous development of tumors at an earlier age and an increased tumor incidence of predominantly lymphomas, but also some solid tumors. Tumorigenesis was accelerated after irradiation of Cadm1 mice, with the reduced latency in tumor formation suggesting there are genes that collaborate with loss of Cadm1 in tumorigenesis. To identify these co-operating genetic events, we performed a Sleeping Beauty transposon-mediated insertional mutagenesis screen in Cadm1 mice, and identified several common insertion sites (CIS) found specifically on a Cadm1-null background (and not wildtype background).


We confirm that Cadm1 is indeed a bona fide tumor suppressor gene and provide new insights into genetic partners that co-operate in tumorigenesis when Cadm1-expression is lost.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

Molecular Cancer 1/2012 Zur Ausgabe


Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.